Nationwide Fund Advisors’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-31,371
Closed -$349K 1351
2017
Q3
$349K Hold
31,371
﹤0.01% 2365
2017
Q2
$281K Hold
31,371
﹤0.01% 2478
2017
Q1
$248K Sell
31,371
-2,477
-7% -$20.2K ﹤0.01% 2491
2016
Q4
$290K Sell
33,848
-1,481
-4% -$12.7K ﹤0.01% 2449
2016
Q3
$290K Hold
35,329
﹤0.01% 2444
2016
Q2
$284K Buy
35,329
+998
+3% +$8K ﹤0.01% 2440
2016
Q1
$231K Sell
34,331
-460
-1% -$3.03K ﹤0.01% 2467
2015
Q4
$274K Buy
34,791
+848
+2% +$6.21K ﹤0.01% 2397
2015
Q3
$194K Hold
33,943
﹤0.01% 2579
2015
Q2
$184K Buy
+33,943
New +$175K ﹤0.01% 2750
2014
Q2
Sell
-25,574
Closed -$89K 3357
2014
Q1
$89K Sell
25,574
-595
-2% -$2.23K ﹤0.01% 2775
2013
Q4
$95K Hold
26,169
﹤0.01% 2972
2013
Q3
$79K Buy
26,169
+15,793
+152% +$44.5K ﹤0.01% 2991
2013
Q2
$41K Buy
+10,376
New +$39.6K ﹤0.01% 2990

Other funds holding NEO

Nationwide Fund Advisors's NEO Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of NeoGenomics (NEO) in Q4 2017, closing a stake of 31,371 shares — an estimated $349K sold.

Nationwide Fund Advisors first reported a position in NEO in Q2 2013 and held it in 14 quarters. The position peaked at $349K in Q3 2017. 132 funds tracked by Wall St. Rank hold NEO as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining NeoGenomics position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 31,371 NeoGenomics shares in Q4 2017, an estimated $349K.
  • Nationwide Fund Advisors first reported a position in NeoGenomics in Q2 2013 and held it in 14 quarters.
  • Nationwide Fund Advisors's NeoGenomics position peaked at $349K in Q3 2017.
  • 132 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.